Works matching IS 17555914 AND DT 2018 AND VI 36 AND IP 1
Results: 9
Hemodynamic impact of pulmonary vasodilators on single ventricle physiology.
- Published in:
- Cardiovascular Therapeutics, 2018, v. 36, n. 1, p. 1, doi. 10.1111/1755-5922.12314
- By:
- Publication type:
- Article
Tetrahydrobiopterin (BH<sub>4</sub>): Targeting endothelial nitric oxide synthase as a potential therapy for pulmonary hypertension.
- Published in:
- Cardiovascular Therapeutics, 2018, v. 36, n. 1, p. 1, doi. 10.1111/1755-5922.12312
- By:
- Publication type:
- Article
The APEX trial: Effects of allopurinol on exercise capacity, coronary and peripheral endothelial function, and natriuretic peptides in patients with cardiac syndrome X.
- Published in:
- Cardiovascular Therapeutics, 2018, v. 36, n. 1, p. 1, doi. 10.1111/1755-5922.12311
- By:
- Publication type:
- Article
The effect of allogeneic cardiac stem cells in left ventricular geometry and function in a rat model of myocardial infarction.
- Published in:
- Cardiovascular Therapeutics, 2018, v. 36, n. 1, p. 1, doi. 10.1111/1755-5922.12313
- By:
- Publication type:
- Article
Warfarin prescription in patients with nonvalvular atrial fibrillation and one non–gender‐related risk factor (CHA<sub>2</sub>DS<sub>2</sub>VASc 1 or 2): A treatment dilemma.
- Published in:
- Cardiovascular Therapeutics, 2018, v. 36, n. 1, p. 1, doi. 10.1111/1755-5922.12310
- By:
- Publication type:
- Article
The effects of single‐ and multiple‐dose administration of bococizumab (RN316/PF‐04950615), a humanized IgG2Δa monoclonal antibody binding proprotein convertase subtilisin/kexin type 9, in hypercholesterolemic subjects treated with and without atorvastatin: Results from four phase I studies
- Published in:
- Cardiovascular Therapeutics, 2018, v. 36, n. 1, p. 1, doi. 10.1111/1755-5922.12309
- By:
- Publication type:
- Article
Effects of 12 weeks of treatment with intravenously administered bococizumab, a humanized monoclonal antibody blocking proprotein convertase subtilisin/kexin type 9, in hypercholesterolemic subjects on high‐dose statin.
- Published in:
- Cardiovascular Therapeutics, 2018, v. 36, n. 1, p. 1, doi. 10.1111/1755-5922.12308
- By:
- Publication type:
- Article
The vasorelaxant effect of antidiabetic drug nateglinide via activation of voltage‐dependent K<sup>+</sup> channels in aortic smooth muscle.
- Published in:
- Cardiovascular Therapeutics, 2018, v. 36, n. 1, p. 1, doi. 10.1111/1755-5922.12299
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Cardiovascular Therapeutics, 2018, v. 36, n. 1, p. 1, doi. 10.1111/1755-5922.12293
- Publication type:
- Article